These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23911856)

  • 1. Regioselective synthesis of 6-substituted-2-amino-5-bromo-4(3H)-pyrimidinones and evaluation of their antiviral activity.
    Singh K; Singh K; Balzarini J
    Eur J Med Chem; 2013 Sep; 67():428-33. PubMed ID: 23911856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 2-methoxy- and 2-methylthio-6-[2'-alkylamino)ethyl]-4(3H)-pyrimidinones with anti-rubella virus activity.
    Botta M; Occhionero F; Nicoletti R; Mastromarino P; Conti C; Magrini M; Saladino R
    Bioorg Med Chem; 1999 Sep; 7(9):1925-31. PubMed ID: 10530941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation, and pharmacophore generation of uracil, 4(3H)-pyrimidinone, and uridine derivatives as potent and selective inhibitors of parainfluenza 1 (Sendai) virus.
    Saladino R; Crestini C; Palamara AT; Danti MC; Manetti F; Corelli F; Garaci E; Botta M
    J Med Chem; 2001 Dec; 44(26):4554-62. PubMed ID: 11741474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis and interferon-inducing activity studies on the antiviral compounds of 2,5,6-trisubstituted-4(3H) pyrimidinone derivatives].
    Liu XY; Xu LJ
    Yao Xue Xue Bao; 1994; 29(2):153-7. PubMed ID: 8042514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro antiviral evaluation of 4-substituted 3,4-dihydropyrimidinones.
    Kumarasamy D; Roy BG; Rocha-Pereira J; Neyts J; Nanjappan S; Maity S; Mookerjee M; Naesens L
    Bioorg Med Chem Lett; 2017 Jan; 27(2):139-142. PubMed ID: 27979594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, cytotoxic effect and antiviral activity of 1-(beta-D-arabinofuranosyl)-5-bromo-N4-substituted cytosine and 1-(beta-D-arabinofuranosyl)-5-bromo-4-methoxypyrimidin-2(1H)-one derivatives.
    Saladino R; Mezzetti M; Mincione E; Palamara AT; Savini P; Marini S
    Nucleosides Nucleotides; 1999; 18(11-12):2499-510. PubMed ID: 10639751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent and selective inhibition of parainfluenza 1 (Sendai) virus by new 6-oxiranyl-, 6-methyloxiranyluracils, and 4(3H)-pyrimidinone derivatives.
    Saladino R; Danti MC; Mincione E; Crestini C; Palamara AT; Savini P; Marini S; Botta M
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1833-8. PubMed ID: 9873443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of new C5-(1-substituted-1,2,3-triazol-4 or 5-yl)-2'-deoxyuridines and their antiviral evaluation.
    Montagu A; Roy V; Balzarini J; Snoeck R; Andrei G; Agrofoglio LA
    Eur J Med Chem; 2011 Feb; 46(2):778-86. PubMed ID: 21232828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of non-nucleosides: 7- and 1,3-substituents of new pyrrolo[2,3-d]pyrimidin-4-ones on antiviral activity.
    Hilmy KM
    Arch Pharm (Weinheim); 2006 Apr; 339(4):174-81. PubMed ID: 16586425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-substituted 2-amino-6-phenyl-4(3H)-pyrimidinones. Antiviral- and interferon-inducing agents.
    Wierenga W; Skulnick HI; Stringfellow DA; Weed SD; Renis HE; Eidson EE
    J Med Chem; 1980 Mar; 23(3):237-9. PubMed ID: 7365739
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and antiviral properties of novel indole-based thiosemicarbazides and 4-thiazolidinones.
    Cihan-Üstündağ G; Gürsoy E; Naesens L; Ulusoy-Güzeldemirci N; Çapan G
    Bioorg Med Chem; 2016 Jan; 24(2):240-6. PubMed ID: 26707844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, docking, and antiviral evaluation of some novel pyrimidinone-based α-aminophosphonates as potent H1N1 and HCoV-229E inhibitors.
    Hekal HA; Hammad OM; El-Brollosy NR; Salem MM; Allayeh AK
    Bioorg Chem; 2024 Jun; 147():107353. PubMed ID: 38615475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of substituted phenyl azetidine-2-one sulphonyl derivatives as potential antimicrobial and antiviral agents.
    Mandal MK; Ghosh S; Bhat HR; Naesens L; Singh UP
    Bioorg Chem; 2020 Nov; 104():104320. PubMed ID: 33142428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydropyrimidinone/1,2,3-triazole hybrid molecules: Synthesis and anti-varicella-zoster virus (VZV) evaluation.
    Kaoukabi H; Kabri Y; Curti C; Taourirte M; Rodriguez-Ubis JC; Snoeck R; Andrei G; Vanelle P; Lazrek HB
    Eur J Med Chem; 2018 Jul; 155():772-781. PubMed ID: 29945100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiviral activity of a new series of 4-isothiazolecarbonitriles.
    Cutrí CC; Garozzo A; Siracusa MA; Sarvá MC; Tempera G; Geremia E; Pinizzotto MR; Guerrera F
    Bioorg Med Chem; 1998 Dec; 6(12):2271-80. PubMed ID: 9925289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of bicyclic pyrimidinone-based HCV NS3 protease inhibitors.
    Glunz PW; Douty BD; Decicco CP
    Bioorg Med Chem Lett; 2003 Mar; 13(5):785-8. PubMed ID: 12617891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel cycloalkylthiophene-imine derivatives bearing benzothiazole scaffold: synthesis, characterization and antiviral activity evaluation.
    Ke S; Wei Y; Yang Z; Wang K; Liang Y; Shi L
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5131-4. PubMed ID: 23920438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Bromo-3-deazaneplanocin and 3-bromo-3-deazaaristeromycin: synthesis and antiviral activity.
    Liu C; Chen Q; Schneller SW
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5182-4. PubMed ID: 22795626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 3-sulphonamido-quinazolin-4(3H)-one derivatives: microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense viruses.
    Selvam P; Vijayalakshimi P; Smee DF; Gowen BB; Julander JG; Day CW; Barnard DL
    Antivir Chem Chemother; 2007; 18(5):301-5. PubMed ID: 18046963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Synthesis Enables Structural Reengineering of Aglaroxin C Leading to Inhibition Bias for Hepatitis C Viral Infection.
    Zhang W; Liu S; Maiga RI; Pelletier J; Brown LE; Wang TT; Porco JA
    J Am Chem Soc; 2019 Jan; 141(3):1312-1323. PubMed ID: 30590924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.